Monroe Capital Provides $20 Million Credit Facility To Cytovance Biologics Inc.

CHICAGO--(BUSINESS WIRE)--Monroe Capital LLC today announced it acted as sole lead arranger and administrative agent on the funding of a $20 million senior credit facility to support the growth of Cytovance Biologics, Inc. (“Cytovance”) by private equity sponsor, Great Point Partners. Based in Oklahoma City, Oklahoma, Cytovance is a contract manufacturing organization (“CMO”) of mammalian and microbial biologics. The company works with biotechnology and pharmaceutical companies in the development and manufacturing of proteins, antibodies, and cell-based therapeutic products. Cytovance supports its customers from clinical development to commercial launch in domestic and international markets.

Help employers find you! Check out all the jobs and post your resume.